UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041996
Receipt number R000047928
Scientific Title A Study Comparing Depressed Patients and Healthy Subjects Using Long-Term ECG and Triaxial Accelerometer
Date of disclosure of the study information 2020/10/05
Last modified on 2025/04/07 18:49:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study Comparing Depressed Patients and Healthy Subjects Using Long-Term ECG and Triaxial Accelerometer

Acronym

A Study Comparing Depressed Patients and Healthy Subjects Using Long-Term ECG and Triaxial Accelerometer

Scientific Title

A Study Comparing Depressed Patients and Healthy Subjects Using Long-Term ECG and Triaxial Accelerometer

Scientific Title:Acronym

A Study Comparing Depressed Patients and Healthy Subjects Using Long-Term ECG and Triaxial Accelerometer

Region

Japan


Condition

Condition

Major depressive disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will use a wearable electrocardiograph (HeartnoteTM) to measure long-term electrocardiograms and a built-in triaxial accelerometer in depressed and healthy patients, and examine the differences between the two groups based on the results of 7 days of measurements. In addition to biostatistical analysis, we will attempt to discriminate between disease states and severity of illness using machine learning.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

heart rate variability

Key secondary outcomes

Beck Depression Inventory, PHQ-9, State-Trait Anxiety Inventory, Hamilton Rating Scale for Depression, Montgomery-Asberg Depression Rating Scale, Physical activity, posture, activity, physical activity, and sleep


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

<for patients>
1) Patients 20 years of age or older with a diagnosis of major depressive disorder according to DSM-5 diagnostic criteria
2) Patients determined by the attending physician to be competent to make consenting decisions.

<for healthy controls>.
1) Healthy individuals with no history of mental illness who have volunteered to participate in the study based on web advertisements, bulletin boards, email recruitment ads, etc., or through their organizations.
2) Those who were 20 years of age or older at the time of obtaining consent.

Key exclusion criteria

1) Patients who may have difficulty applying HeartnoteTM due to skin sensitivity, metal allergies, body hair, etc.
2) Patients with cardiac or physical diseases that can affect ECG or accelerometer assessment data (e.g., arrhythmia, myocardial infarction, Parkinson's disease)
3) Patients who are on treatment that may have a significant effect on the ECG or body movements (e.g., ECT, TMS, beta-blockers, anticholinergics, antiarrhythmics, antihypertensive medications, etc.)
4) Patients with suicidal ideation
5) Patients with comorbid psychiatric disorders other than depression
6) When the principal investigator or sub-investigator decides that it is inappropriate to do so

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Taishiro
Middle name
Last name Kishimoto

Organization

Keio University School of Medicine

Division name

Neuropsychiatry

Zip code

160-8582

Address

Shinanomachi35, Shinjuku, Tokyo, Japan

TEL

0353633492

Email

tkishimoto@keio.jp


Public contact

Name of contact person

1st name Toshiro
Middle name
Last name Horigome

Organization

Keio University School of Medicine

Division name

Neuropsychiatry

Zip code

160-8582

Address

Shinanomachi35, Shinjuku, Tokyo, Japan

TEL

0353633492

Homepage URL


Email

toshiro@keio.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

JSR-Keio University Medical and Chemical Innovation Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Committee

Address

Shinanomachi35, Shinjuku, Tokyo, Japan

Tel

03-5363-3503

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

20200163

Org. issuing International ID_1

Keio University School of Medicine Ethics Committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 05 Day


Related information

URL releasing protocol

none

Publication of results

Unpublished


Result

URL related to results and publications

none

Number of participants that the trial has enrolled

60

Results

It was possible to assess the presence or absence of depressive symptoms with a certain degree of accuracy by applying machine learning to data obtained from long-term electrocardiogram (ECG) and triaxial accelerometer measurements.

Results date posted

2025 Year 04 Month 07 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The male-to-female ratio was 3:7.
The average age was 41.0 years in the healthy control group and 45.0 years in the depression group.
The average BDI (Beck Depression Inventory) score was 5.4 in the healthy control group and 21.0 in the depression group.

Participant flow

Randomization was not performed.

Adverse events

none

Outcome measures

CGI-I, HAMD-17, MADRS, BDI, PHQ-9, STAI

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 08 Month 03 Day

Date of IRB

2020 Year 09 Month 03 Day

Anticipated trial start date

2020 Year 10 Month 05 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2025 Year 03 Month 31 Day


Other

Other related information

<For patients>
The treating physician interviews the attending physician for a General Clinical Impression (CGI) and obtains background information from the medical record, including age, gender, medications, and duration of the disease.The HAMD and MADRS are assessed, and then the subject wears the Heartnote and lives free for 7 days. He will complete a self-administered questionnaire assessment at some point during the 7-day wear. For the self-administered questionnaire, the following information will be enforced
Beck Depression Questionnaire (BDI)
PHQ-9
State-Trait Anxiety Inventory (STAI)
The assessment shall be performed twice per examinee with a minimum of two weeks' interval.


<For healthy controls>.
Information such as age, gender, medical history, and medications will be confirmed in writing.The subject will then wear the Heartnote and live freely with no restrictions for 7 days. He will complete a self-administered questionnaire at any point during the seven days of wear. The following information will be administered for the self-administered questionnaire
Beck Depression Questionnaire (BDI)
PHQ-9
State-Trait Anxiety Inventory (STAI)
Assessments shall be conducted twice with a minimum of two (2) weeks between each examinee.


Management information

Registered date

2020 Year 10 Month 03 Day

Last modified on

2025 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047928